{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:27:47Z","timestamp":1777512467654,"version":"3.51.4"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/nrc866","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T00:15:48Z","timestamp":1032308148000},"page":"616-626","source":"Crossref","is-referenced-by-count":236,"title":["The Molecular and Genetic Basis of Neurological Tumours"],"prefix":"10.1038","volume":"2","author":[{"given":"Yuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Parada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrc866_CR1","volume-title":"Pathology and Genetics of Tumors of the Nervous System","author":"P Kleihues","year":"2000","unstructured":"Kleihues, P. & Cavenee, W. K. Pathology and Genetics of Tumors of the Nervous System (IARC Press, Lyon, 2000).An outstanding and comprehensive textbook on the pathology and genetics of tumours of the nervous system."},{"key":"BFnrc866_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher, E. A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311\u20131333 (2001).","journal-title":"Genes Dev."},{"key":"BFnrc866_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/35052535","volume":"2","author":"EC Holland","year":"2001","unstructured":"Holland, E. C. Gliomagenesis: genetic alterations and mouse models. Nature Rev. Genet. 2, 120\u2013129 (2001).References  2  and  3  are recent comprehensive reviews on the genetics of gliomas.","journal-title":"Nature Rev. Genet."},{"key":"BFnrc866_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#","volume":"89","author":"JM Woodruff","year":"1999","unstructured":"Woodruff, J. M. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am. J. Med. Genet. 89, 23\u201330 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrc866_CR5","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"VM Riccardi","year":"1992","unstructured":"Riccardi, V. M. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis (Johns Hopkins University Press, Baltimore and London, 1992)."},{"key":"BFnrc866_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593\u2013604 (2001).","journal-title":"Cell"},{"key":"BFnrc866_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/excr.2000.5138","volume":"264","author":"Y Zhu","year":"2001","unstructured":"Zhu, Y. & Parada, L. F. Neurofibromin, a tumor suppressor in the nervous system. Exp. Cell Res. 264, 19\u201328 (2001).","journal-title":"Exp. Cell Res."},{"key":"BFnrc866_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307\u2013310 (2000).","journal-title":"Nature"},{"key":"BFnrc866_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/348747a0","volume":"348","author":"S Srivastava","year":"1990","unstructured":"Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. & Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li\u2013Fraumeni syndrome. Nature 348, 747\u2013749 (1990).","journal-title":"Nature"},{"key":"BFnrc866_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233\u20131238 (1990).","journal-title":"Science"},{"key":"BFnrc866_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jnci\/86.13.1011","volume":"86","author":"DJ van Meyel","year":"1994","unstructured":"van Meyel, D. J. et al. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J. Natl Cancer Inst. 86, 1011\u20131017 (1994).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc866_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s004010051024","volume":"97","author":"H Ohgaki","year":"1999","unstructured":"Ohgaki, H. et al. A case history of glioma progression. Acta Neuropathol. 97, 525\u2013532 (1999).","journal-title":"Acta Neuropathol."},{"key":"BFnrc866_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00005072-199301000-00005","volume":"52","author":"DN Louis","year":"1993","unstructured":"Louis, D. N. et al. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J. Neuropathol. Exp. Neurol. 52, 31\u201338 (1993).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR14","first-page":"1324","volume":"54","author":"BK Rasheed","year":"1994","unstructured":"Rasheed, B. K. et al. Alterations of the TP53 gene in human gliomas. Cancer Res. 54, 1324\u20131330 (1994).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/355846a0","volume":"355","author":"D Sidransky","year":"1992","unstructured":"Sidransky, D. et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355, 846\u2013847 (1992).","journal-title":"Nature"},{"key":"BFnrc866_CR16","first-page":"2987","volume":"52","author":"A von Deimling","year":"1992","unstructured":"von Deimling, A. et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 52, 2987\u20132990 (1992).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR17","first-page":"523","volume":"3","author":"K Watanabe","year":"1997","unstructured":"Watanabe, K. et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin. Cancer Res. 3, 523\u2013530 (1997).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc866_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159\u2013170 (1996).","journal-title":"Cell"},{"key":"BFnrc866_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992).","journal-title":"Nature"},{"key":"BFnrc866_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1\u20137 (1994).","journal-title":"Curr. Biol."},{"key":"BFnrc866_CR21","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1128\/MCB.15.8.4249","volume":"15","author":"AM Yahanda","year":"1995","unstructured":"Yahanda, A. M., Bruner, J. M., Donehower, L. A. & Morrison, R. S. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. Cell. Biol. 15, 4249\u20134259 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc866_CR22","first-page":"2746","volume":"55","author":"O Bogler","year":"1995","unstructured":"Bogler, O., Huang, H. J. & Cavenee, W. K. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res. 55, 2746\u20132751 (1995).References  21  and  22  show that  Trp53 -deficient astrocytes have a growth advantage and are susceptible to transformation.","journal-title":"Cancer Res."},{"key":"BFnrc866_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0092-8674(00)81688-8","volume":"100","author":"T Hunter","year":"2000","unstructured":"Hunter, T. Signaling: 2000 and beyond. Cell 100, 113\u2013127 (2000).","journal-title":"Cell"},{"key":"BFnrc866_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3171\/jns.1992.76.5.0792","volume":"76","author":"JA Takahashi","year":"1992","unstructured":"Takahashi, J. A. et al. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76, 792\u2013798 (1992).","journal-title":"J. Neurosurg."},{"key":"BFnrc866_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1006303221064","volume":"44","author":"J Weis","year":"1999","unstructured":"Weis, J. et al. CNTF and its receptor subunits in human gliomas. J. Neurooncol. 44, 243\u2013253 (1999).","journal-title":"J. Neurooncol."},{"key":"BFnrc866_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1073\/pnas.91.2.484","volume":"91","author":"F Yamaguchi","year":"1994","unstructured":"Yamaguchi, F., Saya, H., Bruner, J. M. & Morrison, R. S. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl Acad. Sci. USA 91, 484\u2013488 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ijc.2910600206","volume":"60","author":"A Guha","year":"1995","unstructured":"Guha, A., Dashner, K., Black, P. M., Wagner, J. A. & Stiles, C. D. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int. J. Cancer 60, 168\u2013173 (1995).","journal-title":"Int. J. Cancer"},{"key":"BFnrc866_CR28","first-page":"3213","volume":"52","author":"M Hermanson","year":"1992","unstructured":"Hermanson, M. et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 52, 3213\u20133219 (1992).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR29","first-page":"164","volume":"56","author":"M Hermanson","year":"1996","unstructured":"Hermanson, M. et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 56, 164\u2013171 (1996).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR30","first-page":"3910","volume":"48","author":"M Nister","year":"1988","unstructured":"Nister, M. et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-\u03b1 and their receptors in human malignant glioma cell lines. Cancer Res. 48, 3910\u20133918 (1988).References  28  and  30  are the first to report that astrocytoma cells might establish an autocrine loop of PDGF signalling.","journal-title":"Cancer Res."},{"key":"BFnrc866_CR31","first-page":"5275","volume":"58","author":"L Uhrbom","year":"1998","unstructured":"Uhrbom, L., Hesselager, G., Nister, M. & Westermark, B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58, 5275\u20135279 (1998).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR32","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1101\/gad.903001","volume":"15","author":"C Dai","year":"2001","unstructured":"Dai, C. et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15, 1913\u20131925 (2001).References  31  and  32  describe the effort to model astrocytomas in mice by overexpression of  Pdgf.","journal-title":"Genes Dev."},{"key":"BFnrc866_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1523\/JNEUROSCI.17-01-00125.1997","volume":"17","author":"BN Oumesmar","year":"1997","unstructured":"Oumesmar, B. N., Vignais, L. & Baron-Van Evercooren, A. Developmental expression of platelet-derived growth factor-\u03b1 receptor in neurons and glial cells of the mouse CNS. J. Neurosci. 17, 125\u2013139 (1997).","journal-title":"J. Neurosci."},{"key":"BFnrc866_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1242\/dev.126.3.457","volume":"126","author":"M Fruttiger","year":"1999","unstructured":"Fruttiger, M. et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126, 457\u2013467 (1999).","journal-title":"Development"},{"key":"BFnrc866_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00502-5","volume":"107","author":"P Duchek","year":"2001","unstructured":"Duchek, P., Somogyi, K., Jekely, G., Beccari, S. & Rorth, P. Guidance of cell migration by the Drosophila PDGF\/VEGF receptor. Cell 107, 17\u201326 (2001).","journal-title":"Cell"},{"key":"BFnrc866_CR36","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos, J. L. Ras oncogenes in human cancer: a review. Cancer Res. 49, 4682\u20134689 (1989).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR37","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.onc.1201455","volume":"15","author":"A Guha","year":"1997","unstructured":"Guha, A., Feldkamp, M. M., Lau, N., Boss, G. & Pawson, A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15, 2755\u20132765 (1997).","journal-title":"Oncogene"},{"key":"BFnrc866_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jnen\/60.9.917","volume":"60","author":"L Kluwe","year":"2001","unstructured":"Kluwe, L. et al. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J. Neuropathol. Exp. Neurol. 60, 917\u2013920 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","volume":"59","author":"N Lau","year":"2000","unstructured":"Lau, N. et al. Loss of neurofibromin is associated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma. J. Neuropathol. Exp. Neurol. 59, 759\u2013767 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR40","first-page":"3826","volume":"61","author":"H Ding","year":"2001","unstructured":"Ding, H. et al. Astrocyte-specific expression of activated p21-Ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61, 3826\u20133836 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nature Rev. Cancer 1, 222\u2013231 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc866_CR42","first-page":"150","volume":"56","author":"K Ueki","year":"1996","unstructured":"Ueki, K. et al. CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 56, 150\u2013153 (1996).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005072-199802000-00003","volume":"57","author":"KL Burns","year":"1998","unstructured":"Burns, K. L., Ueki, K., Jhung, S. L., Koh, J. & Louis, D. N. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. J. Neuropathol. Exp. Neurol. 57, 122\u2013130 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR44","first-page":"6321","volume":"54","author":"EE Schmidt","year":"1994","unstructured":"Schmidt, E. E., Ichimura, K., Reifenberger, G. & Collins, V. P. CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54, 6321\u20136324 (1994).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR45","first-page":"4833","volume":"55","author":"J He","year":"1995","unstructured":"He, J., Olson, J. J. & James, C. D. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55, 4833\u20134836 (1995).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR46","first-page":"1065","volume":"13","author":"K Ichimura","year":"1996","unstructured":"Ichimura, K., Schmidt, E. E., Goike, H. M. & Collins, V. P. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13, 1065\u20131072 (1996).","journal-title":"Oncogene"},{"key":"BFnrc866_CR47","first-page":"1250","volume":"57","author":"JF Costello","year":"1997","unstructured":"Costello, J. F. et al. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57, 1250\u20131254 (1997).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","volume":"9","author":"R Buschges","year":"1999","unstructured":"Buschges, R. et al. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol. 9, 435\u2013442; discussion 432\u2013433 (1999).","journal-title":"Brain Pathol."},{"key":"BFnrc866_CR49","first-page":"2387","volume":"7","author":"A Chakravarti","year":"2001","unstructured":"Chakravarti, A. et al. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin. Cancer Res. 7, 2387\u20132395 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc866_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/35092584","volume":"413","author":"P Krimpenfort","year":"2001","unstructured":"Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A. & Berns, A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83\u201386 (2001).","journal-title":"Nature"},{"key":"BFnrc866_CR51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35092592","volume":"413","author":"NE Sharpless","year":"2001","unstructured":"Sharpless, N. E. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86\u201391 (2001).","journal-title":"Nature"},{"key":"BFnrc866_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","volume":"85","author":"M Serrano","year":"1996","unstructured":"Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27\u201337 (1996).","journal-title":"Cell"},{"key":"BFnrc866_CR53","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1101\/gad.14.8.994","volume":"14","author":"S Marino","year":"2000","unstructured":"Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994\u20131004 (2000).","journal-title":"Genes Dev."},{"key":"BFnrc866_CR54","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1101\/gad.12.23.3675","volume":"12","author":"EC Holland","year":"1998","unstructured":"Holland, E. C., Hively, W. P., DePinho, R. A. & Varmus, H. E. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675\u20133685 (1998).","journal-title":"Genes Dev."},{"key":"BFnrc866_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1535-6108(02)00029-6","volume":"1","author":"A Xiao","year":"2002","unstructured":"Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N. & Van Dyke, T. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1, 157\u2013168 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc866_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s004010050711","volume":"94","author":"W Biernat","year":"1997","unstructured":"Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P. & Ohgaki, H. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol. 94, 303\u2013309 (1997).","journal-title":"Acta Neuropathol."},{"key":"BFnrc866_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3171\/jns.1994.81.3.0427","volume":"81","author":"FF Lang","year":"1994","unstructured":"Lang, F. F., Miller, D. C., Koslow, M. & Newcomb, E. W. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J. Neurosurg. 81, 427\u2013436 (1994).","journal-title":"J. Neurosurg."},{"key":"BFnrc866_CR58","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/sj.onc.1203700","volume":"19","author":"G Fulci","year":"2000","unstructured":"Fulci, G. et al. p53 gene mutation and INK4A\u2013ARF deletion appear to be two mutually exclusive events in human glioblastoma. Oncogene 19, 3816\u20133822 (2000).","journal-title":"Oncogene"},{"key":"BFnrc866_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/35096061","volume":"2","author":"CJ Sherr","year":"2001","unstructured":"Sherr, C. J. The INK4A\/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731\u2013737 (2001).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc866_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00005072-199702000-00009","volume":"56","author":"W Biernat","year":"1997","unstructured":"Biernat, W., Kleihues, P., Yonekawa, Y. & Ohgaki, H. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J. Neuropathol. Exp. Neurol. 56, 180\u2013185 (1997).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/79075","volume":"26","author":"KM Reilly","year":"2000","unstructured":"Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E. & Jacks, T. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nature Genet. 26, 109\u2013113 (2000).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.2910560114","volume":"56","author":"J Schlegel","year":"1994","unstructured":"Schlegel, J. et al. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int. J. Cancer 56, 72\u201377 (1994).","journal-title":"Int. J. Cancer"},{"key":"BFnrc866_CR63","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1750-3639.1997.tb00890.x","volume":"7","author":"Y Hayashi","year":"1997","unstructured":"Hayashi, Y. et al. Association of EGFR gene amplification and CDKN2 (p16\/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol. 7, 871\u2013875 (1997).","journal-title":"Brain Pathol."},{"key":"BFnrc866_CR64","first-page":"1122","volume":"61","author":"ML Simmons","year":"2001","unstructured":"Simmons, M. L. et al. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 61, 1122\u20131128 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR65","first-page":"1383","volume":"60","author":"L Frederick","year":"2000","unstructured":"Frederick, L., Wang, X. Y., Eley, G. & James, C. D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 60, 1383\u20131387 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc866_CR66","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","volume":"91","author":"R Nishikawa","year":"1994","unstructured":"Nishikawa, R. et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl Acad. Sci. USA 91, 7727\u20137731 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/gcc.2870070311","volume":"7","author":"D Fults","year":"1993","unstructured":"Fults, D. & Pedone, C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom. Cancer 7, 173\u2013177 (1993).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc866_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1750-3639.1993.tb00721.x","volume":"3","author":"A von Deimling","year":"1993","unstructured":"von Deimling, A. et al. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 3, 19\u201326 (1993).","journal-title":"Brain Pathol."},{"key":"BFnrc866_CR69","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943\u20131947 (1997).","journal-title":"Science"},{"key":"BFnrc866_CR70","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356\u2013362 (1997).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR71","first-page":"2124","volume":"57","author":"DM Li","year":"1997","unstructured":"Li, D. M. & Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor-\u03b2. Cancer Res. 57, 2124\u20132129 (1997).References  69\u201371  identify the tumour-suppressor gene  PTEN.","journal-title":"Cancer Res."},{"key":"BFnrc866_CR72","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/00005072-199807000-00005","volume":"57","author":"Y Tohma","year":"1998","unstructured":"Tohma, Y. et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J. Neuropathol. Exp. Neurol. 57, 684\u2013689 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc866_CR73","doi-asserted-by":"publisher","first-page":"9052","DOI":"10.1073\/pnas.94.17.9052","volume":"94","author":"MP Myers","year":"1997","unstructured":"Myers, M. P. et al. PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl Acad. Sci. USA 94, 9052\u20139057 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR74","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","volume":"280","author":"M Tamura","year":"1998","unstructured":"Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614\u20131617 (1998).","journal-title":"Science"},{"key":"BFnrc866_CR75","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","volume":"273","author":"T Maehama","year":"1998","unstructured":"Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375\u201313378 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrc866_CR76","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1073\/pnas.95.23.13513","volume":"95","author":"MP Myers","year":"1998","unstructured":"Myers, M. P. et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl Acad. Sci. USA 95, 13513\u201313518 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR77","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0955-0674(99)80029-5","volume":"11","author":"SJ Leevers","year":"1999","unstructured":"Leevers, S. J., Vanhaesebroeck, B. & Waterfield, M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11, 219\u2013225 (1999).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrc866_CR78","doi-asserted-by":"publisher","first-page":"15587","DOI":"10.1073\/pnas.95.26.15587","volume":"95","author":"X Wu","year":"1998","unstructured":"Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E. & Sawyers, C. L. The PTEN\/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase\/Akt pathway. Proc. Natl Acad. Sci. USA 95, 15587\u201315591 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","volume":"95","author":"V Stambolic","year":"1998","unstructured":"Stambolic, V. et al. Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29\u201339 (1998).","journal-title":"Cell"},{"key":"BFnrc866_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/75596","volume":"25","author":"EC Holland","year":"2000","unstructured":"Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genet. 25, 55\u201357 (2000).A mouse model that recapitulates cardinal features of human GBM, including microvascular proliferation and necrosis. The study also indicates that the PI3K\u2013AKT pathway has a crucial role in the development of GBM and that neural stem cells are more susceptible to transformation.","journal-title":"Nature Genet."},{"key":"BFnrc866_CR81","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1523\/JNEUROSCI.12-11-04565.1992","volume":"12","author":"BA Reynolds","year":"1992","unstructured":"Reynolds, B. A., Tetzlaff, W. & Weiss, S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12, 4565\u20134574 (1992).","journal-title":"J. Neurosci."},{"key":"BFnrc866_CR82","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707\u20131710 (1992).","journal-title":"Science"},{"key":"BFnrc866_CR83","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1126\/science.1065518","volume":"294","author":"M Groszer","year":"2001","unstructured":"Groszer, M. et al. Negative regulation of neural stem\/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294, 2186\u20132189 (2001).","journal-title":"Science"},{"key":"BFnrc866_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0959-4388(99)80017-8","volume":"9","author":"S Temple","year":"1999","unstructured":"Temple, S. & Alvarez-Buylla, A. Stem cells in the adult mammalian central nervous system. Curr. Opin. Neurobiol. 9, 135\u2013141 (1999).","journal-title":"Curr. Opin. Neurobiol."},{"key":"BFnrc866_CR85","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","volume":"287","author":"FH Gage","year":"2000","unstructured":"Gage, F. H. Mammalian neural stem cells. Science 287, 1433\u20131438 (2000).","journal-title":"Science"},{"key":"BFnrc866_CR86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/35102174","volume":"414","author":"S Temple","year":"2001","unstructured":"Temple, S. The development of neural stem cells. Nature 414, 112\u2013117 (2001).","journal-title":"Nature"},{"key":"BFnrc866_CR87","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1523\/JNEUROSCI.22-03-00614.2002","volume":"22","author":"P Rakic","year":"2002","unstructured":"Rakic, P. Adult neurogenesis in mammals: an identity crisis. J. Neurosci. 22, 614\u2013618 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrc866_CR88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(00)80783-7","volume":"97","author":"F Doetsch","year":"1999","unstructured":"Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M. & Alvarez-Buylla, A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97, 703\u2013716 (1999).","journal-title":"Cell"},{"key":"BFnrc866_CR89","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1523\/JNEUROSCI.21-18-07153.2001","volume":"21","author":"B Seri","year":"2001","unstructured":"Seri, B., Garcia-Verdugo, J. M., McEwen, B. S. & Alvarez-Buylla, A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J. Neurosci. 21, 7153\u20137160 (2001).","journal-title":"J. Neurosci."},{"key":"BFnrc866_CR90","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/35055553","volume":"409","author":"SC Noctor","year":"2001","unstructured":"Noctor, S. C., Flint, A. C., Weissman, T. A., Dammerman, R. S. & Kriegstein, A. R. Neurons derived from radial glial cells establish radial units in neocortex. Nature 409, 714\u2013720 (2001).","journal-title":"Nature"},{"key":"BFnrc866_CR91","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1242\/dev.127.24.5253","volume":"127","author":"P Malatesta","year":"2000","unstructured":"Malatesta, P., Hartfuss, E. & Gotz, M. Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage. Development 127, 5253\u20135263 (2000).","journal-title":"Development"},{"key":"BFnrc866_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/dbio.2000.9962","volume":"229","author":"E Hartfuss","year":"2001","unstructured":"Hartfuss, E., Galli, R., Heins, N. & Gotz, M. Characterization of CNS precursor subtypes and radial glia. Dev. Biol. 229, 15\u201330 (2001).","journal-title":"Dev. Biol."},{"key":"BFnrc866_CR93","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/35067582","volume":"2","author":"A Alvarez-Buylla","year":"2001","unstructured":"Alvarez-Buylla, A., Garcia-Verdugo, J. M. & Tramontin, A. D. A unified hypothesis on the lineage of neural stem cells. Nature Rev. Neurosci. 2, 287\u2013293 (2001).","journal-title":"Nature Rev. Neurosci."},{"key":"BFnrc866_CR94","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1126\/science.289.5485.1754","volume":"289","author":"T Kondo","year":"2000","unstructured":"Kondo, T. & Raff, M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289, 1754\u20131757 (2000).","journal-title":"Science"},{"key":"BFnrc866_CR95","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1535-6108(02)00046-6","volume":"1","author":"RM Bachoo","year":"2002","unstructured":"Bachoo, R. M. et al. Epidermal growth factor receptor and Ink4a\/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269\u2013277 (2002).A provocative study showing that astrocytes can de-differentiate into neural stem cells in response to oncogenic mutations. This provides the first evidence that neural stem cells can result from oncogenic mutations.","journal-title":"Cancer Cell"},{"key":"BFnrc866_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R","volume":"41","author":"KR Jessen","year":"1998","unstructured":"Jessen, K. R. & Mirsky, R. Origin and early development of Schwann cells. Microsc. Res. Tech. 41, 393\u2013402 (1998).","journal-title":"Microsc. Res. Tech."},{"key":"BFnrc866_CR97","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0092-8674(00)80583-8","volume":"96","author":"SJ Morrison","year":"1999","unstructured":"Morrison, S. J., White, P. M., Zock, C. & Anderson, D. J. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96, 737\u2013749 (1999).The study is the first to prospectively identify and isolate stem cells from the peripheral nervous system.","journal-title":"Cell"},{"key":"BFnrc866_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ng0293-122","volume":"3","author":"E Legius","year":"1993","unstructured":"Legius, E., Marchuk, D. A., Collins, F. S. & Glover, T. W. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet. 3, 122\u2013126 (1993).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR99","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L Side","year":"1997","unstructured":"Side, L. et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N. Engl. J. Med. 336, 1713\u20131720 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc866_CR100","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/gcc.2870040411","volume":"4","author":"W Xu","year":"1992","unstructured":"Xu, W. et al. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosom. Cancer 4, 337\u2013342 (1992).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc866_CR101","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ng0995-90","volume":"11","author":"SD Colman","year":"1995","unstructured":"Colman, S. D., Williams, C. A. & Wallace, M. R. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nature Genet. 11, 90\u201392 (1995).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR102","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1086\/515504","volume":"61","author":"E Serra","year":"1997","unstructured":"Serra, E. et al. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am. J. Hum. Genet. 61, 512\u2013519 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrc866_CR103","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E","volume":"28","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen, S. A. et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosom. Cancer 28, 425\u2013431 (2000).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc866_CR104","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1172\/JCI7610","volume":"105","author":"JE DeClue","year":"2000","unstructured":"DeClue, J. E. et al. Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J. Clin. Invest. 105, 1233\u20131241 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnrc866_CR105","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","volume":"8","author":"CI Brannan","year":"1994","unstructured":"Brannan, C. I. et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019\u20131029 (1994).","journal-title":"Genes Dev."},{"key":"BFnrc866_CR106","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng0794-353","volume":"7","author":"T Jacks","year":"1994","unstructured":"Jacks, T. et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet. 7, 353\u2013361 (1994).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR107","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","volume":"286","author":"K Cichowski","year":"1999","unstructured":"Cichowski, K. et al. Mouse models of tumor development in neurofibromatosis type 1. Science 286, 2172\u20132176 (1999).This study provides the first evidence that loss of both alleles of  Nf1  is a rate-limiting step in neurofibroma formation.","journal-title":"Science"},{"key":"BFnrc866_CR108","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","volume":"158","author":"D Muir","year":"2001","unstructured":"Muir, D., Neubauer, D., Lim, I. T., Yachnis, A. T. & Wallace, M. R. Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am. J. Pathol. 158, 501\u2013513 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrc866_CR109","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","volume":"9","author":"E Serra","year":"2000","unstructured":"Serra, E. et al. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet. 9, 3055\u20133064 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrc866_CR110","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/hmg\/9.7.1059","volume":"9","author":"JL Rutkowski","year":"2000","unstructured":"Rutkowski, J. L., Wu, K., Gutmann, D. H., Boyer, P. J. & Legius, E. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum. Mol. Genet. 9, 1059\u20131066 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrc866_CR111","doi-asserted-by":"publisher","first-page":"30740","DOI":"10.1074\/jbc.M001702200","volume":"275","author":"LS Sherman","year":"2000","unstructured":"Sherman, L. S., Atit, R., Rosenbaum, T., Cox, A. D. & Ratner, N. Single cell Ras-GTP analysis reveals altered ras activity in a subpopulation of neurofibroma schwann cells but not fibroblasts. J. Biol. Chem. 275, 30740\u201330745 (2000).References  112\u2013114  show that Schwann cells, not fibroblasts, are  NF1 -deficient cells within neurofibromas.","journal-title":"J. Biol. Chem."},{"key":"BFnrc866_CR112","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0092-8674(95)90470-0","volume":"82","author":"KS Vogel","year":"1995","unstructured":"Vogel, K. S., Brannan, C. I., Jenkins, N. A., Copeland, N. G. & Parada, L. F. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82, 733\u2013742 (1995).","journal-title":"Cell"},{"key":"BFnrc866_CR113","first-page":"325","volume":"11","author":"HA Kim","year":"1995","unstructured":"Kim, H. A., Rosenbaum, T., Marchionni, M. A., Ratner, N. & DeClue, J. E. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11, 325\u2013335 (1995).","journal-title":"Oncogene"},{"key":"BFnrc866_CR114","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1128\/MCB.17.2.862","volume":"17","author":"HA Kim","year":"1997","unstructured":"Kim, H. A., Ling, B. & Ratner, N. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol. 17, 862\u2013872 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc866_CR115","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.191.1.181","volume":"191","author":"DA Ingram","year":"2000","unstructured":"Ingram, D. A. et al. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J. Exp. Med. 191, 181\u2013188 (2000).References  112\u2013115  describe abnormal properties of cells that are present in neurofibromas.","journal-title":"J. Exp. Med."},{"key":"BFnrc866_CR116","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1084\/jem.194.1.57","volume":"194","author":"DA Ingram","year":"2001","unstructured":"Ingram, D. A. et al. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J. Exp. Med. 194, 57\u201369 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrc866_CR117","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.1068452","volume":"296","author":"Y Zhu","year":"2002","unstructured":"Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K. & Parada, L. F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920\u2013922 (2002).Identifies that disruption of  NF1  in Schwann-cell lineage initiates neurofibroma formation, and that the heterozygous state of the tumour's environment is crucial in its development.","journal-title":"Science"},{"key":"BFnrc866_CR118","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1073\/pnas.87.14.5435","volume":"87","author":"AG Menon","year":"1990","unstructured":"Menon, A. G. et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl Acad. Sci. USA 87, 5435\u20135439 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc866_CR119","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/gcc.2870100405","volume":"10","author":"E Legius","year":"1994","unstructured":"Legius, E. et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosom. Cancer 10, 250\u2013255 (1994).References  118  and  119  show that disruption in  TP53  is involved in malignant progression of MPNSTs.","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc866_CR120","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","volume":"286","author":"KS Vogel","year":"1999","unstructured":"Vogel, K. S. et al. Mouse tumor model for neurofibromatosis type 1. Science 286, 2176\u20132179 (1999).Along with reference  107 , these studies show that p53 cooperates with Nf1 to promote the development of MPNSTs in mice.","journal-title":"Science"},{"key":"BFnrc866_CR121","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0002-9440(10)65504-6","volume":"155","author":"HP Kourea","year":"1999","unstructured":"Kourea, H. P., Orlow, I., Scheithauer, B. W., Cordon-Cardo, C. & Woodruff, J. M. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am. J. Pathol. 155, 1855\u20131860 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrc866_CR122","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","volume":"155","author":"GP Nielsen","year":"1999","unstructured":"Nielsen, G. P. et al. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation. Am. J. Pathol. 155, 1879\u20131884 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrc866_CR123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A","volume":"26","author":"JM Berner","year":"1999","unstructured":"Berner, J. M. et al. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosom. Cancer 26, 151\u2013160 (1999).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc866_CR124","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0002-9440(10)65508-3","volume":"155","author":"HP Kourea","year":"1999","unstructured":"Kourea, H. P., Cordon-Cardo, C., Dudas, M., Leung, D. & Woodruff, J. M. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas. Am. J. Pathol. 155, 1885\u20131891 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnrc866_CR125","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ng731","volume":"29","author":"TJ MacDonald","year":"2001","unstructured":"MacDonald, T. J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS\/MAPK pathway as therapeutic targets for metastatic disease. Nature Genet. 29, 143\u2013152 (2001).","journal-title":"Nature Genet."},{"key":"BFnrc866_CR126","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/415436a","volume":"415","author":"SL Pomeroy","year":"2002","unstructured":"Pomeroy, S. L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436\u2013442 (2002).","journal-title":"Nature"},{"key":"BFnrc866_CR127","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.274.5286.373","volume":"274","author":"JR Bischoff","year":"1996","unstructured":"Bischoff, J. R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373\u2013376 (1996).","journal-title":"Science"},{"key":"BFnrc866_CR128","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/35101008","volume":"1","author":"F McCormick","year":"2001","unstructured":"McCormick, F. Cancer gene therapy: fringe or cutting edge? Nature Rev. Cancer 1, 130\u2013141 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc866_CR129","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/med.1022","volume":"21","author":"P Traxler","year":"2001","unstructured":"Traxler, P. et al. Tyrosine kinase inhibitors: from rational design to clinical trials. Med. Res. Rev. 21, 499\u2013512 (2001).","journal-title":"Med. Res. Rev."},{"key":"BFnrc866_CR130","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","volume":"287","author":"JB Gibbs","year":"2000","unstructured":"Gibbs, J. B. Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969\u20131973 (2000).","journal-title":"Science"},{"key":"BFnrc866_CR131","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/nm1097-1145","volume":"3","author":"MJ Parr","year":"1997","unstructured":"Parr, M. J. et al. Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nature Med. 3, 1145\u20131149 (1997).","journal-title":"Nature Med."},{"key":"BFnrc866_CR132","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1172\/JCI9054","volume":"104","author":"GI Shapiro","year":"1999","unstructured":"Shapiro, G. I. & Harper, J. W. Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Invest. 104, 1645\u20131653 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrc866_CR133","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1126\/science.2648568","volume":"243","author":"MC Raff","year":"1989","unstructured":"Raff, M. C. Glial cell diversification in the rat optic nerve. Science 243, 1450\u20131455 (1989).","journal-title":"Science"},{"key":"BFnrc866_CR134","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1523\/JNEUROSCI.12-12-04816.1992","volume":"12","author":"BP Fulton","year":"1992","unstructured":"Fulton, B. P., Burne, J. F. & Raff, M. C. Visualization of O-2A progenitor cells in developing and adult rat optic nerve by quisqualate-stimulated cobalt uptake. J. Neurosci. 12, 4816\u20134833 (1992).","journal-title":"J. Neurosci."},{"key":"BFnrc866_CR135","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0896-6273(00)80469-9","volume":"20","author":"AR Calver","year":"1998","unstructured":"Calver, A. R. et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20, 869\u2013882 (1998).","journal-title":"Neuron"},{"key":"BFnrc866_CR136","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0092-8674(02)00677-3","volume":"109","author":"Q Zhou","year":"2002","unstructured":"Zhou, Q. & Anderson, D. J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61\u201373 (2002).","journal-title":"Cell"},{"key":"BFnrc866_CR137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0092-8674(02)00678-5","volume":"109","author":"QR Lu","year":"2002","unstructured":"Lu, Q. R. et al. Common developmental requirement for Olig function indicates a motor neuron\/oligodendrocyte connection. Cell 109, 75\u201386 (2002).","journal-title":"Cell"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrc866.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc866","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc866.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T21:31:58Z","timestamp":1650403918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BFnrc866"],"URL":"https:\/\/doi.org\/10.1038\/nrc866","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}